news aktuell GmbH

VORN Bioenergy announces appointments to leadership team

15.1.2026 10:58:53 CET | news aktuell GmbH | Press Release

Share

Regensburg. VORN Bioenergy today announces the appointment of Jörg Lennertz as Chief Executive Officer and Manuel Fernández Durán as Chief Financial Officer. Jörg and Manuel together with Michael Wallis Olausson form the new management team.

Jörg Lennertz is an experienced leader in the bioenergy sector. Joining VORN Bioenergy from Uniper, he played a key role in building the company’s multi-gigawatt European renewable energy business. Jörg’s experience, from project development through to execution as well as in scaling up, will be valuable for implementing VORN Bioenergy’s ambitious growth strategy across Germany, Italy, the Iberian Peninsula and Poland. Jörg Lennertz succeeds Thorsten Holl who over the past three years, restructured the company, repositioned it, and established its foundations for growth.

Jörg Lennertz says: “VORN Bioenergy has decades of experience in realizing and commercially optimizing biomethane assets, and I’m delighted to join them as they enter a new phase of execution, providing sizeable feedstock and offtake opportunities across Europe. I’m looking forward to continuing this momentum as we aim to be the partner of choice for current and future feedstock suppliers and offtakers, and continue to support Europe’s decarbonisation.”

Manuel Fernández brings over 18 years of CFO experience, recently at BlueFloat Energy. He brings deep knowledge in project financing and proven ability to build and scale finance teams for long-term growth.

The management team at VORN Bioenergy is completed by Michael Wallis Olausson, who joined as Chief Operating Officer (COO) in February 2025 brings deep expertise from over 15 years biogas industry experience, particularly on project construction and operation.

Chris Archer, Head of Macquarie Asset Management, Green Investments EMEA, the shareholder of VORN Bioenergy, says: “We would like to express our sincere thanks to Thorsten Holl and Dirk Simons for their leadership and dedication in recent years. As we look to the future, the complementary strengths Jörg, Manuel and Michael bring position VORN exceptionally well to deliver on its growth ambitions.”

The VORN Bioenergy Group is an innovative developer, deliverer and operator of biomethane plants in Europe. The company, which has been independent since 2022, can look back on more than 20 years of project experience and has realised more than 40 bioenergy projects in Europe. The company is based in Regensburg, Germany, and its operational focus is on Germany, Italy, Spain and Poland. VORN Bioenergy pursues the consistent goal of operating emission-free and producing two TWh of biomethane per year by 2030.

Contacts

Wilfried.Sauer.extern@vornbioenergy.com
Phone: +49174 49 60 605

Subscribe to releases from news aktuell GmbH

Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from news aktuell GmbH

FEV analysis: TCO cut by up to 33 percent through range extender trucks11.2.2026 12:27:02 CET | Press Release

Aachen – FEV has published new analysis results on the economic efficiency of electrified commercial vehicles as part of an internal research program. The evaluation of extensive techno-economic data shows: depending on the driving cycle, through trucks with range extender architecture (REEV/Hybrid BEV) the total cost of ownership (TCO) can be reduced by up to 33 percent compared to conventional diesel trucks – while also significantly reducing CO₂ emissions. Even in the most unfavorable long-haul scenario, the TCO declined by approximately 14 percent.

BRP-Rotax: Aircraft Meets Racetrack – Luke Czepiela Flies the Racing Line at Bahrain International Circuit10.2.2026 17:00:00 CET | Press Release

BRP‑Rotax unveils its latest milestone in aviation with Aircraft Meets Racetrack. In an unprecedented accomplishment for the Bahrain International Circuit, Red Bull athlete and Rotax Ambassador Luke Czepiela became the first pilot to fly this Grand Prix track’s complete racing line from the air, showcasing the capabilities of Rotax powered aviation in a dramatic low‑level performance.

Grünenthal licenses exclusive Canadian rights to testosterone replacement therapy Nebido® to Apotex5.2.2026 16:03:03 CET | Press Release

Aachen, Germany & Toronto, Canada, February 5, 2026 – Grünenthal, a global leader in pain management and related diseases, and Apotex Inc. ("Apotex"), the largest Canadian-based pharmaceutical company, today announced they have entered into a licensing agreement whereby Apotex will have the exclusive Canadian rights to Nebido® (testosterone undecanoate), a long-acting injectable therapy indicated for the treatment of male hypogonadism (testosterone deficiency).[1] [1] https://www.medicines.org.uk/emc/product/14631/smpc

HEIDELBERG achieves significant improvement in profitability after nine months of FY 2025/26 – strategic realignment proceeding as planned5.2.2026 08:02:33 CET | Press Release

Sales after nine months up on previous year, increasing by some 6.1 percent Adjusted EBITDA considerably better than in previous year – efficiency measures having a clear impact Incoming orders down on previous year, as expected, due to underlying economic conditions and absence of drupa effect Successful positioning in security, defense, and energy technologies Full-year forecast confirmed despite challenging environment

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye